Recombinant
RabMAb

Recombinant Anti-HNF-4-alpha antibody [EPR16885] - ChIP Grade (ab181604)

Publishing research using ab181604? Please let us know so that we can cite the reference in this datasheet.

ab181604 has been referenced in 6 publications.

  • Danoy M  et al. Optimized protocol for the hepatic differentiation of induced pluripotent stem cells in a fluidic microenvironment. Biotechnol Bioeng 116:1762-1776 (2019). PubMed: 30883676
  • Lesaffer B  et al. Comparison of the Opn-CreER and Ck19-CreER Drivers in Bile Ducts of Normal and Injured Mouse Livers. Cells 8:N/A (2019). PubMed: 31027317
  • Zhang N  et al. Elevated hepatic expression of H19 long noncoding RNA contributes to diabetic hyperglycemia. JCI Insight 3:N/A (2018). PubMed: 29769440
  • Jia Y  et al. Dapagliflozin Aggravates Renal Injury via Promoting Gluconeogenesis in db/db Mice. Cell Physiol Biochem 45:1747-1758 (2018). PubMed: 29495021
  • Gao YH  et al. VHL deficiency augments anthracycline sensitivity of clear cell renal cell carcinomas by down-regulating ALDH2. Nat Commun 8:15337 (2017). IHC . PubMed: 28643803
  • Deng J  et al. H19 lncRNA alters methylation and expression of Hnf4a in the liver of metformin-exposed fetuses. Cell Death Dis 8:e3175 (2017). WB . PubMed: 29215608

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Sign up